Disc Medicine Overview
Disc Medicine Target Price
Analysts' 12-month price predictions for IRON.
Get informed when a big investor buys or sells
+ FollowShare Price
$76.26
Average Target Price
$82.50
8.2% upside
8.2% upside2 analysts in the last 4 months
High: $85 | Low: $80
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-15 | Morgan Stanley | $85 | 11.5% upside |  |
| 2026-05-14 | Morgan Stanley | $80 | 4.9% upside | |
| 2026-02-17 | Wedbush | $88 | 15.4% upside | |
| 2026-02-17 | Cantor FitzgeraldKristen Kluska | $125 | 63.9% upside | |
| 2026-02-17 | Morgan Stanley | $75 |  1.7% downside | |
| 2026-02-17 | Stifel Nicolaus | $110 | 44.2% upside | |
| 2026-02-17 | BMO CapitalEvan Seigerman | $100 | 31.1% upside | |
| 2026-01-08 | Morgan Stanley | $120 | 57.4% upside | |
| 2025-12-08 | Raymond JamesMartin Auster | $117 | 53.4% upside | |
| 2025-11-10 | Truist Financial | $114 | 49.5% upside | |
| 2025-10-17 | National Bank | $153 | 100.6% upside | |
| 2025-10-17 | Raymond James | $108 | 41.6% upside | |
| 2025-10-17 | WedbushDavid Nierengarten | $110 | 44.2% upside | |
| 2024-11-05 | ScotiabankGreg Harrison | $70 | 8.2% downside | |
| 2024-11-05 | BMO CapitalEvan David Seigerman | $112 | 46.9% upside | |
| 2024-10-23 | JefferiesRoger Song | $89 | 16.7% upside | |
| 2024-09-16 | H.C. WainwrightDouglas Tsao | $70 | 8.2% downside | |
| 2024-08-22 | Wells FargoTiago Fauth | $75 | 1.7% downside | |
| 2024-08-08 | Raymond JamesDanielle Brill | $50 | 34.4% downside | |
| 2024-06-17 | BMO CapitalEvan David Seigerman | $70 | 8.2% downside | |
| 2024-05-10 | Raymond JamesDanielle Brill | $43 | 43.6% downside | |
| 2024-04-02 | BMO CapitalEvan David Seigerman | $50 | 34.4% downside | |
| 2024-04-01 | Stifel NicolausBen Burnett | $71 | 6.9% downside | |
| 2024-04-01 | WedbushDavid Nierengarten | $43 | 43.6% downside | |
| 2024-04-01 | Raymond JamesDanielle Brill | $40 | 47.5% downside | |